Skip to Primary Navigation

Skip to main content

FTC secures $12m for medtech pre‑merger violations

A photo of the facade of the Federal Trade Commission building entrance, including the name of the organization in brass and brass grill work.
Photo: Kevin Carter/Getty Images

Kevin Kinsella

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Companies involved in a medical device acquisition face record penalties after failing to comply with Hart Scott Rodino Act reporting requirements.

The Federal Trade Commission (FTC) has announced it has secured $12m in civil penalties to resolve allegations that Edwards Lifesciences Corp and Genesis MedTech Group Limited violated the Hart‑Scott‑Rodino (HSR) Act during Edwards’ acquisition of JC Medical.

Under a proposed final judgment filed in the US District Court

, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience